Zobrazeno 1 - 10
of 27
pro vyhledávání: '"N P, Christiansen"'
Autor:
N. P. Christiansen, Sunil Abhyankar, Shannon Y. DeRienzo, Wane M. O'Neal, P. Jean Henslee-Downey, K. Godder, Kuang-Yueh Chiang, Kerry D. Bridges
Publikováno v:
Pharmacotherapy. 20:1175-1178
Study Objective. To evaluate the pharmacokinetics and use of intravenous human cytomegalovirus immune globulin (CytoGam) in allogeneic bone marrow transplantation (BMT). Design. Prospective, nonrandomized, nonblinded, single-center study. Setting. Un
Autor:
Lee C, SH Abhyankar, N. P. Christiansen, Kerry D. Bridges, Adrian P. Gee, Henslee-Downey Pj, Rudolph S. Parrish, S.S. Geier, Pati Ar, Linda J. Hazlett, K. Godder, Karen S. Goon-Johnson, K. Y. Chiang
Publikováno v:
Journal of Clinical Oncology. 18:1856-1866
PURPOSE: To extend access to bone marrow transplantation (BMT), we used partially mismatched related donors (PMRD) for pediatric patients with acute leukemia. In this report we sought to determine pretransplantation factors that might predict outcome
Publikováno v:
The Journal of Immunology. 146:949-957
The CD45 Ag family is a group of high m.w. glycoproteins that are expressed on the plasma membranes of all leukocytes. CD45 has protein tyrosine phosphatase activity and appears to regulate signal transduction and lymphocyte activation by specific as
Autor:
Mary M. Horowitz, Koen van Biesen, Cesar O. Freytes, Julie M. Vose, Stephen D. Nimer, Peter H. Wiernik, Roger H. Herzig, Philip L. McCarthy, Linda J. Burns, Sergio Giralt, John Gibson, Jing Tao-Wu, Joseph Wiley, James O. Armitage, Charles F. LeMaistre, Hillard M. Lazarus, N. P. Christiansen, David P. Schenkein, Asad Bashey, Fausto R. Loberiza, Douglas Rizzo, Finn Bo Petersen, Robert Peter Gale
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 10(2)
We evaluated the results of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with diffuse aggressive non-Hodgkin lymphoma (NHL) in first relapse (Rel 1) or second complete remission (CR 2). Data were evaluated
Autor:
Langdon L. Miller, Mark Ashby, Dennie V. Jones, Charles A. Linker, Lawrence T. Goodnough, C H Weaver, Timothy A. Yang, Joseph W. Fay, N. P. Christiansen, George Somlo, William I. Bensinger, Mark C. Benyunes, Paolo Anderlini, Roger H. Herzig, Joseph P. Lynch
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 9(6)
This study assessed the ability of various schedules of recombinant human thrombopoietin (rhTPO) to enhance mobilization of peripheral blood progenitor cells (PBPCs) in 134 patients with cancer undergoing high-dose chemotherapy and autologous PBPC tr
Autor:
N. P. Christiansen, Kuang-Yueh Chiang, K Bridges, Sunil Abhyankar, Henslee-Downey Pj, L. J. Hazlett, Lee C, R. S. Parrish, K. T. Godder, F. van Rhee
Publikováno v:
Bone marrow transplantation. 28(12)
Epstein–Barr virus (EBV) is closely associated with the progressive and often fatal lymphoproliferative disorders (LPD) in post bone marrow transplantation (BMT) and immunocompromised hosts. The incidence increases significantly when alternative do
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(9)
Administration of growth factors prior to chemotherapy (priming) may reduce myelosuppression and provide an alternative to the use of stem cell support for the delivery of dose-intensive therapy. It is possible, however, that such priming may worsen
Publikováno v:
Cytometry. 26(4)
Previous attempts to characterize harvested marrow and peripheral blood stem cell (PBSC) in order to predict time to and quality of engraftment post autologous bone marrow transplant (autoBMT) have included use of in vitro colony forming unit (CFU) a
Autor:
S H, Bernstein, N P, Christiansen, J P, Fay, R, Brown, R, Herzig, S, Frankel, L, Blumenson, G P, Herzig
Publikováno v:
Experimental hematology. 24(12)
Given the limitations of bone marrow transplantation (BMT), alternative approaches to deliver dose-intensive regimens without stem cell support are needed. Administration of hematopoietic growth factors before high-dose chemotherapy (priming) may red
Autor:
J, Jurlander, M A, Caligiuri, T, Ruutu, M R, Baer, M P, Strout, A R, Oberkircher, L, Hoffmann, E D, Ball, D A, Frei-Lahr, N P, Christiansen, A M, Block, S, Knuutila, G P, Herzig, C D, Bloomfield
Publikováno v:
Blood. 88(6)
The AML1/ETO fusion transcript is expressed in virtually all patients with t(8;21) (q22;q22) acute myeloid leukemia (AML). The fusion transcript can be detected by reverse transcription-polymerase chain reaction (RT-PCR) in most of these patients in